Amedisys Inc. (Nasdaq: AMED) filed paperwork with the U.S. Securities and Change Fee on Friday, saying it has agreed to divest “sure” places to a subsidiary of house well being and hospice firm VitalCaring.

The divestiture was a means for Amedisys to keep away from additional antitrust considerations from regulators earlier than becoming a member of UnitedHealth Group (NYSE: UNH).

UnitedHealth Group's Optum agreed to purchase Amedisys in June of final 12 months for a purchase order worth of $3.3 billion. Optum already owns LHC Group, one other of the nation's largest house well being care firms.

Baton Rouge, Louisiana-based Amedisys has 521 healthcare facilities in 37 states and the District of Columbia. It provides house care, hospice, palliative and excessive acuity house care.

In Might, a report emerged that UnitedHealth Group and Amedisys have been working with regulators on a divestiture package deal for “greater than 100 places.”

Shortly thereafter, a non-public equity-backed purchaser for these places emerged. Residence Well being Care Information reported that the customer was VitalCaring, the Dallas-based house well being and hospice firm led by April Anthony. VitalCaring is supported by The Vistria Group and Nautic Companions.

VitalCaring then reportedly pulled out of the deal, citing disagreements over the worth of these places as soon as they left the Amedisys community, sources advised HHCN.

HHCN additionally reported on the time that it was doubtless that each events would return to the desk. VitalCaring is likely one of the few rising house care suppliers with adequate capital assist to hold out an acquisition of this dimension.

Now the 2 sides have agreed on the deal, though particulars are minimal. Amedisys' 8-Ok submitting didn’t specify a purchase order worth or the variety of places.

In line with monetary paperwork, the divestiture settlement closing is contingent on the UnitedHealth Group deal going by means of.

“The completion of the Divestiture is topic to a lot of circumstances, together with the completion of the beforehand introduced merger transaction (the “Merger Transaction”) contemplated by the Settlement and Plan of Merger, dated June 26, 2023 (the “Merger Settlement”), by and amongst UnitedHealth Group, Aurora Holdings Merger Sub Inc., a completely owned subsidiary of UnitedHealth Group (“Merger Sub”), and Amedisys, pursuant to which Merger Sub will merge with and into Amedisys (the “Merger”) on the phrases and topic to the circumstances set forth within the Merger Settlement, with Amedisys surviving the Merger as a completely owned subsidiary of UnitedHealth Group,” the submitting stated.

The transaction is predicted to shut within the second half of 2024.